Scientists from UC Davis Center for Surgical Bioengineering, the MIND Institute and UC Berkeley’s Murthy Lab are developing ...

A patient death in a CRISPR trial halts gene editing studies, raising critical safety questions. What this means for the ...

GlobalData is the parent company of Clinical Trials Arena. "Ocugen sets sights on Phase III after GA gene therapy win" was ...

Two of Opus's seven gene therapy assets are in clinical trials, with additional programs expected to enter the clinic.

The company has made more than 50 deals for its proprietary technology as it looks forward to a potentially “transformative” ...

Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to ...

For those born with certain types of congenital deafness, the cochlear implant has been a positive and enabling technology.

"Regulatory flexibility must be tailored for cell and gene therapies," commented FDA Commissioner Marty Makary. "These are ...

GEN’s first virtual event of 2026—we present a group of outstanding researchers and thought-leaders to discuss the latest advances and challenges in delivering genetic therapies.

The new method is designed to focus specifically on pain-related signals, without interfering with normal activity in other ...

Sarepta Therapeutics Inc. fell Monday after reporting its embattled gene therapy is expected to miss fourth-quarter sales ...

A preclinical study uncovered a new gene therapy that targets pain centers in the brain while eliminating the risk of ...